Method of cancer screening; method of cancer treatment; and method of diabetes treatment

Abstract

A method of cancer screening comprising the steps of administering the Blood CA 27,29 testing procedure; if the result is positive administering a mammogram; if the result is positive administering an needle biopsy; if the result is positive administering a PET scan; if the result is positive administering a blood tumor cell count. If all of the foregoing steps are positive, the cancer is treated by applying imiquimod transdermally to rotating sites, preferably by mixing ALDARA (TM) (imiquimod) 5% cream with an equal amount of H base cream (TM), administering a BCG vaccination, and orally administering VALTREX (TM) (valacyclovir) twice daily. The foregoing treatment method is also effective in treating Type I diabetes, MS, and other epidermal cancers.

1 . A method of cancer screening comprising the steps of: 
 administering the Blood CA 27,29 testing procedure; and    the subsequent step of treating the cancer identified by the preceding step by transdermal administration of imiquimod, injection of BCG vaccine, and oral administration of VALTREX (TM) (valacyclovir).    
   
   
       2 . The method of cancer screening according to  claim 1  wherein the step transdermally administering imiquimod is carried out by mixing ¼ cc of ALDARA (TM) (imiquimod) 5% cream with ¼ cc H base cream (TM) and transdermally administering the resulting mixture.  
   
   
       3 . A method of treating duct cell breast cancer comprising the steps of: 
 providing a quantity of ALDARA (TM) (imiquimod) 5% cream;    providing a quantity of H base cream (TM);    mixing ¼ cc. of the ALDARA (TM) (imiquimod) 5% cream with ¼ cc. of the H base cream (TM) and transdermally administering the resulting mixture to the patient;    administering a BCG vaccination; and    orally administering VALTREX (TM) (valacyclovir) tablets.    
   
   
       4 . The method of treating duct cell breast cancer according to  claim 3  wherein the ALDARA (TM) (imiquimod) 5% cream/H base cream mixture is applied daily and the progress of the procedure is monitored using the Blood CA 27,29 testing procedure.  
   
   
       5 . The method of treating duct cell breast cancer according to  claim 3  wherein the BCG vaccination is administered every tree months and 500 mg VALTREX (TM) (valacyclovir) tablets are orally administered twice daily.  
   
   
       6 . The method of treating duct cell breast cancer according to  claim 5  wherein the progress of the procedure is monitored using the Blood CA 27,29 testing procedure.  
   
   
       7 . A method of treating Type I diabetes comprising the steps of: 
 providing a quantity of ALDARA (TM) (imiquimod) 5% cream;    providing a quantity of H base cream (TM);    mixing ¼ cc. of the ALDARA (TM) (imiquimod) 5% cream with ¼ cc. of the H base cream (TM) and transdermally administering the resulting mixture to the patient;    administering a BCG vaccination; and    orally administering VALTREX (TM) (valacyclovir) tablets.    
   
   
       8 . The method of treating Type I diabetes according to  claim 7  wherein the ALDARA (TM) (imiquimod) 5% cream/H base cream mixture is applied daily, the BCG vaccination is administered every three months and 500 mg VALTREX (TM) (valacyclovir) tablets are orally administered twice daily.  
   
   
       9 . A method of treating multiple sclerosis comprising the steps of: 
 providing a quantity of ALDARA (TM) (imiquimod) 5% cream;    providing a quantity of H base cream (TM);    mixing ¼ cc. of the ALDARA (TM) (imiquimod) 5% cream with ¼ cc. of the H base cream (TM) and transdermally administering the resulting mixture to the patient;    administering a BCG vaccination; and    orally administering VALTREX (TM) (valacyclovir) tablets.    
   
   
       10 . The method of treating multiple sclerosis according to  claim 9  wherein the ALDARA (TM) (imiquimod) 5% cream/H base cream mixture is applied daily, the BCG vaccination is administered every three months and 500 mg VALTREX (TM) (valacyclovir) tablets are orally administered twice daily.